Latest news
BI-1808 Receives FDA Fast Track Designation in Ovarian Cancer - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 20:14:04 GMTFDA Grants Fast Track Designation to BioInvent's BI-1808 for Ovarian Cancer - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 18:25:09 GMTBioInvent wins FDA Fast Track for BI-1808 after encouraging ovarian cancer data - AllSciAllSci · Fri, 07 Aug 2026 16:28:01 GMTUS FDA Fast-tracks Aclaris’ Modzatinib for Lichen Planus - The Dermatology DigestThe Dermatology Digest · Fri, 07 Aug 2026 15:34:47 GMTHAYA’s FDA fast-track win puts heart aging in focus - Longevity.TechnologyLongevity.Technology · Fri, 07 Aug 2026 13:38:35 GMTBioInvent says FDA grants Fast Track designation for BI-1808 in ovarian cancer - BitgetBitget · Fri, 07 Aug 2026 09:19:03 GMTAclaris Therapeutics Receives Fast Track Designation for Modzatinib (ATI-2138) for Moderate to Severe Lichen Planus (LP) - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 20:35:00 GMTIovance Biotherapeutics Reports 2Q 2026 Revenue Growth, Margin Expansion and FDA Fast Track Designation for Lifileucel in Soft Tissue Sarcomas - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:15:00 GMT